Yu Huang

US Patent:

8211679, Jul 3, 2012

Filed:

Feb 25, 2008

Appl. No.:

12/036859

Inventors:

Rathin Datta - Chicago IL, US
Rahul Basu - Naperville IL, US
Hans E. Grethlein - Syracuse NY, US
Richard W. Baker - Palo Alto CA, US
Yu Huang - Palo Alto CA, US

Assignee:

Coskata, Inc. - Warrenville IL

International Classification:

C12P 7/14

US Classification:

435162, 435 71

Abstract:

Ethanol and other liquid products produced by contacting carbon monoxide (CO) and/or a mixture of CO(carbon dioxide) and H(hydrogen) with a microorganism in a bioreactor are separated using a combination of distillation and vapor permeation membranes. The bioreactor passes an effluent with an ethanol concentration of 1 to 6 wt % to a distillation column that produces an overhead vapor stream enriched in ethanol. A series of vapor permeation membranes retain ethanol as retentate and produce a 99 wt % or higher ethanol product. Ethanol depleted permeate streams flow back to the column and the bioreactor. Coupling a bioreactor with distillation and pervaporation efficiently and economically separates ethanol when present at low concentration in an aqueous fermentation broth. The separation arrangement may also include a flash zone ahead of the distillation column to raise the concentration of the ethanol in the input stream to the distillation column.

US Patent:

20220367001, Nov 17, 2022

Filed:

May 25, 2022

Appl. No.:

17/824098

Inventors:

- Tarrytown NY, US
Yu Huang - Ossining NY, US

International Classification:

G16B 5/20
G06F 17/11
G01N 33/68

Abstract:

Methods of predicting an in vivo serum concentration of an antibody with a post-translational modification of interest after administration of the antibody are provided, as are methods for predicting a subject's exposure to post-translational variants of the antibody. The methods include predicting a percentage of the antibody with the post-translational modification of interest using an in vivo rate constant determined for the post-translational modification, and multiplying the predicted percentage of the antibody with the post-translational modification of interest by the in vivo concentration of the antibody to determine the concentration of the antibody with the post-translational modification of interest.

US Patent:

20220271834, Aug 25, 2022

Filed:

Dec 22, 2021

Appl. No.:

17/559659

Inventors:

- Tinley Park IL, US
Richard J. Pimpinella - Frankfort IL, US
Bulent Kose - Burr Ridge IL, US
Yu Huang - Orland Park IL, US
Fei Jia - Tinley Park IL, US

Assignee:

Panduit Corp. - Tinley Park IL

International Classification:

H04B 10/077

Abstract:

A test apparatus has at least one optical source, a high-speed photodetector, a microcontroller or processor, and electrical circuitry to power and drive the at least one optical source, photodetector, and microcontroller or processor and for measuring the frequency response of a multimode optical fiber under test. The test apparatus can utilize an optical pulse waveform with a light adapter to measure of the channel under test. It can also uses a correction method to de-embeed a chromatic bandwidth of the source from the encircled flux modal chromatic bandwidth. The correction method can use correction functions obtained for different type of VCSELs to estimate the optical channel bandwidth when used with VCSEL transceivers.

US Patent:

20230089727, Mar 23, 2023

Filed:

Sep 16, 2022

Appl. No.:

17/946757

Inventors:

- Tarrytown NY, US
Yu Huang - Ossining NY, US
Xiaojing Zheng - Gaithersburg MD, US
Ning Li - New Canaan CT, US

International Classification:

G01N 33/68
G01N 30/72
G01N 30/88
G01N 30/86

Abstract:

The present invention generally pertains to methods of characterizing at least one protein of interest in a biological sample. In particular, the present invention pertains to the use of automated iterative tandem mass spectrometry (AIMS) to identify, quantify and characterize at least one protein of interest and/or biomarker from a biological sample such as plasma.

US Patent:

20210340267, Nov 4, 2021

Filed:

Mar 5, 2021

Appl. No.:

17/193586

Inventors:

- TARRYTOWN NY, US
Drew Dudgeon - Union NJ, US
Yu Huang - Ossining NY, US
Rosalynn Molden - Fox Island WA, US
William Olson - Yorktown Heights NY, US
Matthew Sleeman - Yorktown Heights NY, US
Dimitris Skokos - New York NY, US
Bei Wang - Hastings-on-Hudson NY, US

International Classification:

C07K 16/28
A61P 35/00
A61K 45/06
A61K 39/395

Abstract:

Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR), compositions comprising the antibodies or antigen-binding fragments thereof, and methods of using the same, including, e.g., methods of treatment using the same.

US Patent:

20210297152, Sep 23, 2021

Filed:

Jan 28, 2021

Appl. No.:

17/161116

Inventors:

- Tinley Park IL, US
Richard J. Pimpinella - Frankfort IL, US
Bulent Kose - Burr Ridge IL, US
Brett Lane - Hinsdale IL, US
Yu Huang - Orland Park IL, US
Asher S. Novick - Chicago IL, US

Assignee:

Panduit Corp. - Tinley Park IL

International Classification:

H04B 10/073
H04B 10/2581

Abstract:

Methods for estimating the Effective Modal Bandwidth (EMB) of laser optimized Multimode Fiber (MMF) at a specified wavelength, λ, based on the measured EMB at a first reference measurement wavelength, λ. In these methods the Differential Mode Delay (DMD) of a MMF is measured and the Effective Modal Bandwidth (EMB) is computed at a first measurement wavelength. By extracting signal features such as centroids, peak power, pulse widths, and skews, as described in this disclosure, the EMB can be estimated at a second specified wavelength with different degrees of accuracy. The first method estimates the EMB at the second specified wavelength based on measurements at the reference wavelength. The second method predicts if the EMB at the second specified wavelength is equal or greater than a specified bandwidth limit.

US Patent:

20210297757, Sep 23, 2021

Filed:

Jul 11, 2019

Appl. No.:

17/260310

Inventors:

- Tinley Park IL, US
Richard J. Pimpinella - Frankfort IL, US
Robert A. Reid - Battle Ground IN, US
Bulent Kose - Burr Ridge IL, US
Yu Huang - Orland Park IL, US
Asher S. Novick - Chicago IL, US

Assignee:

Panduit Corp. - Tinley Park IL

International Classification:

H04Q 11/00

Abstract:

A fiber optic interconnection assembly has a plurality of leaf components and a plurality of spine components. Each leaf component of the plurality of leaf components is connected to each spine component of the plurality of spine components. Each spine components of the plurality of spine components is connected to each leaf component of the plurality of leaf components. Wherein the connections for each leaf component to each of the spine components is at a different wavelength and the connections for each spine component to each of the leaf components is at a different wavelength.

US Patent:

20210241448, Aug 5, 2021

Filed:

Apr 19, 2021

Appl. No.:

17/233991

Inventors:

- Tinley Park IL, US
Richard J. Pimpinella - Frankfort IL, US
Yu Huang - Orland Park IL, US
Bulent Kose - Burr Ridge IL, US
William Kidd - Shorewood IL, US

Assignee:

Panduit Corp. - Tinley Park IL

International Classification:

G06T 7/00
G02B 6/38
G01M 11/00
H04N 5/232
G06K 9/46
H04N 5/225
H04N 5/33
H04N 5/355

Abstract:

Embodiments of the present invention provide an improved method of determining splice losses of mechanically terminated optical connectors in the field, without the need of terminating both sides of the fiber link. Embodiments of the present invention also provide means for improving the quality of mechanical splices as utilized in pre-polished fiber optic connectors for terminating single-mode and multimode optical fibers in the field.